Valrubicin

Valrubicin is an anthracycline chemotherapy drug infused directly into the bladder (intravesical therapy). It is mainly used to treat Bacillus Calmette-Guérin (BCG)-refractory carcinoma in situ of the bladder in patients who cannot undergo or refuse surgical removal (cystectomy). It is grouped under the following drug class(es): Anthracyclines, Antineoplastic agents, Cytotoxics and Topoisomerase inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Valtaxin and Valstar Preservative Free. Its PubChem CID is 454216.

CAS No 56124-62-0
Molecular Formula C34H36F3NO13
Molecular Weight 723.6 g/mol
Synonyms [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate

Frequently Asked Questions